Cancer and Rare Diseases are areas where genomics can demonstrate immediate diagnostic advances, and where Australia has strong clinical, diagnostic and research expertise. The flagships are collaborative clinical studies, implemented through the extensive network of partner organisations that make up Australian Genomics.
Patients from every Australian state and territory are recruited into flagship projects and the data from their clinical care drives the national diagnostic networks, thus providing the evidence on genomic medicine. This information is used to shape recommendations relating to the program areas, such as education, ethics, policy, health economics and data.
The flagships are investigating how genomics can:
- Diagnose disease early, rapidly, accurately and cost-effectively – avoiding further testing
- Improve clinical care and enable treatment options based on a person’s genetic information
- Help families plan for the future, equipped with the knowledge of their genetic information
- Manage disease risk and make precision therapy increasingly possible